speb/financial-data huggingface dataset:
CMCT cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -2606000.00
CMCT cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -8000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 29353000.00
CMCT income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 26000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1014372000.00
CMCT cash_flow (quarterly, 2025-03-31) — Sale Of Business: 0.00
CMCT cash_flow (quarterly, 2025-03-31) — Sale Of Investment Properties: 0.00
CMCT income_statement (quarterly, 2025-03-31) — Selling General And Administration: 2181000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Share Issued: 7546.00
CMCT income_statement (quarterly, 2025-03-31) — Special Income Charges: -26000.00
CMCT cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 55000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 313844000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -14927000.00
CMCT income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -5460.00
CMCT income_statement (quarterly, 2025-03-31) — Tax Provision: 121000.00
CMCT income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
CMCT balance_sheet (quarterly, 2025-03-31) — Total Assets: 882343000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 801239000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Total Debt: 512658000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 315434000.00
CMCT income_statement (quarterly, 2025-03-31) — Total Expenses: 27511000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 566909000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 756994000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 496792000.00
CMCT income_statement (quarterly, 2025-03-31) — Total Unusual Items: -26000.00
CMCT income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -26000.00
CMCT balance_sheet (quarterly, 2025-03-31) — Working Capital: 55232000.00
CMCT income_statement (quarterly, 2025-06-30) — +Operating Expense: 8065000.00
CMCT income_statement (quarterly, 2025-06-30) — +Total Revenue: 29689000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 25342000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 4126000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1001791000.00
CMCT cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: 26000.00
CMCT cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 740000.00
CMCT income_statement (quarterly, 2025-06-30) — Average Dilution Earnings: 0.00
CMCT income_statement (quarterly, 2025-06-30) — Basic Average Shares: 7540.00
CMCT income_statement (quarterly, 2025-06-30) — Basic EPS: -1894.00
CMCT cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 49125000.00
CMCT cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -6435000.00
CMCT cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -6435000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Capital Stock: 326480000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 27769000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 27769000.00
CMCT cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -5430000.00
CMCT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 16281000.00
CMCT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -5069000.00
CMCT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -2479000.00
CMCT cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 618000.00
CMCT cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 3071000.00
CMCT cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -25000.00
CMCT cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 48000.00
CMCT cash_flow (quarterly, 2025-06-30) — Change In Payable: -3649000.00
CMCT cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -3649000.00
CMCT cash_flow (quarterly, 2025-06-30) — Change In Receivables: -421000.00
CMCT cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -976000.00
CMCT cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -421000.00
CMCT cash_flow (quarterly, 2025-06-30) — Changes In Cash: 8733000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Common Stock: 1000.00
CMCT cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: 0.00
CMCT balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -26866000.00
CMCT income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 18892000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Current Assets: 132233000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Current Debt: 22904000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 22904000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 62177000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Current Notes Payable: 22904000.00
CMCT cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -93000.00
CMCT cash_flow (quarterly, 2025-06-30) — Deferred Tax: -93000.00
CMCT cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 6293000.00
CMCT income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 6264000.00
CMCT cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 6293000.00
CMCT income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 6264000.00
CMCT income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 7540.00
CMCT income_statement (quarterly, 2025-06-30) — Diluted EPS: -1894.00
CMCT income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -14279000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 13931000.00
CMCT income_statement (quarterly, 2025-06-30) — EBIT: 1183000.00
CMCT income_statement (quarterly, 2025-06-30) — EBITDA: 7476000.00
CMCT income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: -437000.00
CMCT cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 437000.00
CMCT cash_flow (quarterly, 2025-06-30) — End Cash Position: 57858000.00
CMCT cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 16281000.00
CMCT cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -8914000.00
CMCT income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1801000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 3459000.00
CMCT income_statement (quarterly, 2025-06-30) — Gross Profit: 10797000.00
CMCT income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 221000.00
CMCT cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 110000.00
CMCT income_statement (quarterly, 2025-06-30) — Interest Expense: 10176000.00
CMCT income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 10176000.00
CMCT cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 9349000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Invested Capital: 508739000.00
CMCT cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -5069000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Investment Properties: 704775000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 33298000.00
CMCT cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 41302000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Loans Receivable: 51094000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 512701000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 512701000.00
CMCT cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 41302000.00
CMCT cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -17473000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 33298000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Minority Interest: 1161000.00
CMCT income_statement (quarterly, 2025-06-30) — Minority Interests: 152000.00
CMCT cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -394000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Net Debt: 507836000.00
CMCT income_statement (quarterly, 2025-06-30) — Net Income: -8999000.00
CMCT income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -14279000.00
CMCT income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -9151000.00
CMCT income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -8999000.00
CMCT income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -8999000.00
CMCT cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -9151000.00
CMCT income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -9151000.00
CMCT income_statement (quarterly, 2025-06-30) — Net Interest Income: -10176000.00
CMCT cash_flow (quarterly, 2025-06-30) — Net Investment Properties Purchase And Sale: 0.00
CMCT cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 23829000.00
CMCT cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 23829000.00
CMCT income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -10176000.00
CMCT cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -2118000.00
CMCT cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 1760000.00
CMCT cash_flow (quarterly, 2025-06-30) — Net Preferred Stock Issuance: 0.00
CMCT balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 296154000.00
CMCT income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 8588000.00
CMCT income_statement (quarterly, 2025-06-30) — Normalized Income: -8120520.00
CMCT cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -2479000.00
CMCT cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 624000.00
CMCT income_statement (quarterly, 2025-06-30) — Operating Income: 2732000.00
CMCT income_statement (quarterly, 2025-06-30) — Operating Revenue: 29689000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 7546.00
CMCT income_statement (quarterly, 2025-06-30) — Other Gand A: 1801000.00
CMCT income_statement (quarterly, 2025-06-30) — Other Income Expense: -1549000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 3459000.00
CMCT cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 3000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 11260000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 9372000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Other Receivables: 19155000.00
CMCT income_statement (quarterly, 2025-06-30) — Other Special Charges: 88000.00
CMCT income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
CMCT balance_sheet (quarterly, 2025-06-30) — Payables: 39273000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 39273000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 326479000.00
CMCT cash_flow (quarterly, 2025-06-30) — Preferred Stock Dividend Paid: -5430000.00
CMCT income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 5280000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 326479000.00
CMCT cash_flow (quarterly, 2025-06-30) — Preferred Stock Payments: 0.00
CMCT income_statement (quarterly, 2025-06-30) — Pretax Income: -8993000.00
CMCT cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -394000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Receivables: 74375000.00
CMCT income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 18863000.00
CMCT income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 6293000.00
CMCT income_statement (quarterly, 2025-06-30) — Rent Expense Supplemental: 16974000.00
CMCT cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -17473000.00
CMCT cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
CMCT balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 30089000.00
CMCT income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 803000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1028658000.00
CMCT cash_flow (quarterly, 2025-06-30) — Sale Of Investment Properties: 0.00
CMCT income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1801000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Share Issued: 7546.00
CMCT income_statement (quarterly, 2025-06-30) — Special Income Charges: -1112000.00
CMCT cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 55000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 299613000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -30325000.00
CMCT income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -233520.00
CMCT income_statement (quarterly, 2025-06-30) — Tax Provision: 158000.00
CMCT income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
CMCT balance_sheet (quarterly, 2025-06-30) — Total Assets: 885024000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 812314000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Total Debt: 535605000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 300774000.00
CMCT income_statement (quarterly, 2025-06-30) — Total Expenses: 26957000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 584250000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 752792000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 522073000.00
CMCT income_statement (quarterly, 2025-06-30) — Total Unusual Items: -1112000.00
CMCT income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -1112000.00
CMCT balance_sheet (quarterly, 2025-06-30) — Working Capital: 70056000.00
CMCT income_statement (quarterly, 2025-09-30) — +Operating Expense: 9493000.00
CMCT income_statement (quarterly, 2025-09-30) — +Total Revenue: 26234000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 31757000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 3379000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1000454000.00
CMCT cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: 26000.00
CMCT cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 291000.00
CMCT income_statement (quarterly, 2025-09-30) — Average Dilution Earnings: 0.00
CMCT income_statement (quarterly, 2025-09-30) — Basic Average Shares: 7540.00
CMCT income_statement (quarterly, 2025-09-30) — Basic EPS: -2352.00
CMCT cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 57858000.00
CMCT cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -2916000.00
CMCT cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -2916000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Capital Stock: 327872000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 17320000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 17320000.00
CMCT cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -5282000.00
CMCT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -14302000.00
CMCT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 929000.00
CMCT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 3742000.00
CMCT cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 4587000.00
CMCT cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 1349000.00
CMCT cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -901000.00
CMCT cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -1729000.00
CMCT cash_flow (quarterly, 2025-09-30) — Change In Payable: 9267000.00
CMCT cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 9267000.00
CMCT cash_flow (quarterly, 2025-09-30) — Change In Receivables: 621000.00
CMCT cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 8607000.00
CMCT cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 621000.00
CMCT cash_flow (quarterly, 2025-09-30) — Changes In Cash: -9631000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Common Stock: 3000.00
CMCT cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: 0.00
CMCT balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -45938000.00
CMCT income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 18325000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Current Assets: 122810000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Current Debt: 20428000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 20428000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 70796000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Current Notes Payable: 20428000.00
CMCT cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -32000.00
CMCT cash_flow (quarterly, 2025-09-30) — Deferred Tax: -32000.00
CMCT cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 7352000.00
CMCT income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 7345000.00
CMCT cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 7352000.00
CMCT income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 7345000.00
CMCT income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 7540.00
CMCT income_statement (quarterly, 2025-09-30) — Diluted EPS: -2352.00
CMCT income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -17736000.00
CMCT cash_flow (quarterly, 2025-09-30) — Dividends Received Cfi: 0.00
CMCT balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 18611000.00
CMCT income_statement (quarterly, 2025-09-30) — EBIT: -2200000.00
CMCT income_statement (quarterly, 2025-09-30) — EBITDA: 5152000.00
CMCT income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: -697000.00
CMCT cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: 697000.00
CMCT cash_flow (quarterly, 2025-09-30) — End Cash Position: 48227000.00
CMCT cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -14302000.00
CMCT cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 826000.00
CMCT cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -778000.00
CMCT income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 679000.00
CMCT income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 2148000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 3427000.00
CMCT income_statement (quarterly, 2025-09-30) — Gross Profit: 7909000.00
CMCT income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 0.00
CMCT cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 174000.00
CMCT income_statement (quarterly, 2025-09-30) — Interest Expense: 10312000.00
CMCT income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 10312000.00
CMCT cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 9666000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Invested Capital: 481829000.00
CMCT cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 929000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Investment Properties: 702671000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 32601000.00
CMCT cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 1220000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Loans Receivable: 51517000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 507339000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 507339000.00
CMCT cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 1220000.00
CMCT cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -9335000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 32601000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Minority Interest: 1020000.00
CMCT income_statement (quarterly, 2025-09-30) — Minority Interests: 131000.00
CMCT cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
CMCT balance_sheet (quarterly, 2025-09-30) — Net Debt: 510447000.00
CMCT income_statement (quarterly, 2025-09-30) — Net Income: -12455000.00
CMCT income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -17736000.00
CMCT income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -12586000.00
CMCT income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -12455000.00
CMCT income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -12455000.00
CMCT cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -12586000.00
CMCT income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -12586000.00
CMCT income_statement (quarterly, 2025-09-30) — Net Interest Income: -10312000.00
CMCT cash_flow (quarterly, 2025-09-30) — Net Investment Properties Purchase And Sale: 1161000.00
CMCT cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -8115000.00
CMCT cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -8115000.00
CMCT income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -10312000.00
CMCT cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -905000.00
CMCT cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 2684000.00
CMCT cash_flow (quarterly, 2025-09-30) — Net Preferred Stock Issuance: 0.00
CMCT balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 278504000.00
CMCT income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 5071000.00
CMCT income_statement (quarterly, 2025-09-30) — Normalized Income: -12518990.00
CMCT cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 3742000.00
CMCT cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -81000.00
CMCT income_statement (quarterly, 2025-09-30) — Operating Income: -1584000.00
CMCT income_statement (quarterly, 2025-09-30) — Operating Revenue: 26234000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 7892.00
CMCT income_statement (quarterly, 2025-09-30) — Other Gand A: 2148000.00
CMCT income_statement (quarterly, 2025-09-30) — Other Income Expense: -616000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 3427000.00
CMCT cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 110000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 10317000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 10740000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Other Receivables: 19687000.00
CMCT income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
CMCT balance_sheet (quarterly, 2025-09-30) — Payables: 50368000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 50368000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 327869000.00
CMCT cash_flow (quarterly, 2025-09-30) — Preferred Stock Dividend Paid: -5282000.00
CMCT income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 5281000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 327869000.00
CMCT cash_flow (quarterly, 2025-09-30) — Preferred Stock Payments: 0.00
CMCT income_statement (quarterly, 2025-09-30) — Pretax Income: -12512000.00
CMCT cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
CMCT balance_sheet (quarterly, 2025-09-30) — Receivables: 74583000.00
CMCT income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 18318000.00
CMCT income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 7352000.00
CMCT income_statement (quarterly, 2025-09-30) — Rent Expense Supplemental: 16141000.00
CMCT cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -9335000.00
CMCT cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
CMCT balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 30907000.00
CMCT income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 598000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1046395000.00
CMCT cash_flow (quarterly, 2025-09-30) — Sale Of Investment Properties: 1161000.00
CMCT income_statement (quarterly, 2025-09-30) — Selling General And Administration: 2148000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Share Issued: 7892.00
CMCT income_statement (quarterly, 2025-09-30) — Special Income Charges: -598000.00
CMCT cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 55000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 281931000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -49365000.00
CMCT income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 17010.00
CMCT income_statement (quarterly, 2025-09-30) — Tax Provision: 74000.00
CMCT income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
CMCT balance_sheet (quarterly, 2025-09-30) — Total Assets: 871826000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 789270000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Total Debt: 527767000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 282951000.00
CMCT income_statement (quarterly, 2025-09-30) — Total Expenses: 27818000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 588875000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 749016000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 518079000.00
CMCT income_statement (quarterly, 2025-09-30) — Total Unusual Items: 81000.00
CMCT income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 81000.00
CMCT balance_sheet (quarterly, 2025-09-30) — Working Capital: 52014000.00
CMCT income_statement (annual, 2025-12-31) — +Operating Expense: 33792000.00
CMCT income_statement (quarterly, 2025-12-31) — +Operating Expense: 7493000.00
CMCT income_statement (annual, 2025-12-31) — +Total Revenue: 116669000.00
CMCT income_statement (quarterly, 2025-12-31) — +Total Revenue: 28451000.00
CMCT balance_sheet (annual, 2025-12-31) — Accounts Payable: 26979000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 26979000.00
CMCT balance_sheet (annual, 2025-12-31) — Accounts Receivable: 2598000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 2598000.00
CMCT balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1019044000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1019044000.00
CMCT cash_flow (annual, 2025-12-31) — Amortization Of Securities: 103000.00
CMCT cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: 25000.00
CMCT cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 2177000.00
CMCT cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 978000.00
CMCT balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 65859000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 65859000.00
CMCT income_statement (annual, 2025-12-31) — Basic Average Shares: 9190.00
CMCT income_statement (quarterly, 2025-12-31) — Basic Average Shares: 15840.00
CMCT income_statement (annual, 2025-12-31) — Basic EPS: -6708.00
CMCT income_statement (quarterly, 2025-12-31) — Basic EPS: -1120.00
CMCT cash_flow (annual, 2025-12-31) — Beginning Cash Position: 52868000.00
CMCT cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 48227000.00
CMCT cash_flow (annual, 2025-12-31) — Capital Expenditure: -20786000.00
CMCT cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -5119000.00
CMCT cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -20786000.00
CMCT cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -5119000.00
CMCT balance_sheet (annual, 2025-12-31) — Capital Stock: 310449000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Capital Stock: 310449000.00
CMCT balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 15439000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 15439000.00
CMCT balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 15439000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 15439000.00
CMCT cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -21959000.00
CMCT cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -5282000.00
CMCT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -4568000.00
CMCT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -6753000.00
CMCT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -11980000.00
CMCT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -2683000.00
CMCT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 5788000.00
CMCT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 3317000.00
CMCT cash_flow (annual, 2025-12-31) — Change In Account Payable: 1482000.00
CMCT cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -2087000.00
CMCT cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 2607000.00
CMCT cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 2371000.00
CMCT cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -1619000.00
CMCT cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 398000.00
CMCT cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -2799000.00
CMCT cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -169000.00
CMCT cash_flow (annual, 2025-12-31) — Change In Payable: 10233000.00
CMCT cash_flow (quarterly, 2025-12-31) — Change In Payable: 2121000.00
CMCT cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 10233000.00
CMCT cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 2121000.00
CMCT cash_flow (annual, 2025-12-31) — Change In Receivables: 597000.00
CMCT cash_flow (quarterly, 2025-12-31) — Change In Receivables: 25000.00
CMCT cash_flow (annual, 2025-12-31) — Change In Working Capital: 9019000.00
CMCT cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 4746000.00
CMCT cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 597000.00
CMCT cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 25000.00
CMCT cash_flow (annual, 2025-12-31) — Changes In Cash: -15183000.00
CMCT cash_flow (quarterly, 2025-12-31) — Changes In Cash: -10542000.00
CMCT balance_sheet (annual, 2025-12-31) — Common Stock: 3000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Common Stock: 3000.00
CMCT cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: 0.00
CMCT cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: 0.00
CMCT balance_sheet (annual, 2025-12-31) — Common Stock Equity: -45085000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -45085000.00
CMCT income_statement (annual, 2025-12-31) — Cost Of Revenue: 73130000.00
CMCT income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 17143000.00
CMCT balance_sheet (annual, 2025-12-31) — Current Assets: 116992000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Current Assets: 116992000.00
CMCT balance_sheet (annual, 2025-12-31) — Current Debt: 10449000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Current Debt: 10449000.00
CMCT balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 10449000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 10449000.00
CMCT balance_sheet (annual, 2025-12-31) — Current Liabilities: 82213000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 82213000.00
CMCT balance_sheet (annual, 2025-12-31) — Current Notes Payable: 0.00
CMCT balance_sheet (quarterly, 2025-12-31) — Current Notes Payable: 0.00
CMCT cash_flow (annual, 2025-12-31) — Deferred Income Tax: -137000.00
CMCT cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 12000.00
CMCT cash_flow (annual, 2025-12-31) — Deferred Tax: -137000.00
CMCT cash_flow (quarterly, 2025-12-31) — Deferred Tax: 12000.00
CMCT cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 27199000.00
CMCT cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 6920000.00
CMCT income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 27081000.00
CMCT income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 6912000.00
CMCT cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 27199000.00
CMCT cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 6920000.00
CMCT income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 27081000.00
CMCT income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 6912000.00
CMCT income_statement (annual, 2025-12-31) — Diluted Average Shares: 9190.00
CMCT income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 15840.00
CMCT income_statement (annual, 2025-12-31) — Diluted EPS: -6708.00
CMCT income_statement (quarterly, 2025-12-31) — Diluted EPS: -1120.00
CMCT income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -61648000.00
CMCT income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -17735000.00
CMCT balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 22819000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 22819000.00
CMCT income_statement (annual, 2025-12-31) — EBIT: 1113000.00
CMCT income_statement (quarterly, 2025-12-31) — EBIT: -1477000.00
CMCT income_statement (annual, 2025-12-31) — EBITDA: 28312000.00
CMCT income_statement (quarterly, 2025-12-31) — EBITDA: 5443000.00
CMCT income_statement (annual, 2025-12-31) — Earnings From Equity Interest: -3760000.00
CMCT income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: -1475000.00
CMCT cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 3760000.00
CMCT cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: 1475000.00
CMCT cash_flow (annual, 2025-12-31) — End Cash Position: 37685000.00
CMCT cash_flow (quarterly, 2025-12-31) — End Cash Position: 37685000.00
CMCT cash_flow (annual, 2025-12-31) — Financing Cash Flow: -4568000.00
CMCT cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -6753000.00
CMCT cash_flow (annual, 2025-12-31) — Free Cash Flow: -14998000.00
CMCT cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -1802000.00
CMCT cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -530000.00
CMCT cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 149000.00
CMCT income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: -298000.00
CMCT income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 679000.00
CMCT income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 0.00
CMCT income_statement (annual, 2025-12-31) — General And Administrative Expense: 6711000.00
CMCT income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 581000.00
CMCT balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 439000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 439000.00
CMCT income_statement (annual, 2025-12-31) — Gross Profit: 43539000.00
CMCT income_statement (quarterly, 2025-12-31) — Gross Profit: 11308000.00
CMCT income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 3692000.00
CMCT income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 3471000.00
CMCT cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 384000.00
CMCT cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 100000.00
CMCT income_statement (annual, 2025-12-31) — Interest Expense: 40191000.00
CMCT income_statement (quarterly, 2025-12-31) — Interest Expense: 9945000.00
CMCT income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 40191000.00
CMCT income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 9945000.00
CMCT cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 36407000.00
CMCT cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 9706000.00
CMCT balance_sheet (annual, 2025-12-31) — Invested Capital: 464683000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Invested Capital: 464683000.00
CMCT cash_flow (annual, 2025-12-31) — Investing Cash Flow: -11980000.00
CMCT cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -2683000.00
CMCT balance_sheet (annual, 2025-12-31) — Investment Properties: 698087000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Investment Properties: 698087000.00
CMCT balance_sheet (annual, 2025-12-31) — Investments And Advances: 31095000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 31095000.00
CMCT balance_sheet (annual, 2025-12-31) — Investmentsin Joint Venturesat Cost: 31095000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Investmentsin Joint Venturesat Cost: 31095000.00
CMCT cash_flow (annual, 2025-12-31) — Issuance Of Debt: 55504000.00
CMCT cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 3969000.00
CMCT balance_sheet (annual, 2025-12-31) — Line Of Credit: 10449000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 10449000.00
CMCT balance_sheet (annual, 2025-12-31) — Loans Receivable: 0.00
CMCT balance_sheet (quarterly, 2025-12-31) — Loans Receivable: 0.00
CMCT balance_sheet (annual, 2025-12-31) — Long Term Debt: 499319000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 499319000.00
CMCT balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 499319000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 499319000.00
CMCT cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 55504000.00
CMCT cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 3969000.00
CMCT cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -35047000.00
CMCT cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -5633000.00
CMCT balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 31095000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 31095000.00
CMCT balance_sheet (annual, 2025-12-31) — Minority Interest: 888000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Minority Interest: 888000.00
CMCT income_statement (annual, 2025-12-31) — Minority Interests: 573000.00
CMCT income_statement (quarterly, 2025-12-31) — Minority Interests: 132000.00
CMCT cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -1178000.00
CMCT cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 31000.00
CMCT balance_sheet (annual, 2025-12-31) — Net Debt: 494329000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Net Debt: 494329000.00
CMCT income_statement (annual, 2025-12-31) — Net Income: -39002000.00
CMCT income_statement (quarterly, 2025-12-31) — Net Income: -11434000.00
CMCT income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -61648000.00
CMCT income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -17735000.00
CMCT income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -39575000.00
CMCT income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -11566000.00
CMCT income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -39002000.00
CMCT income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -11434000.00
CMCT income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -39002000.00
CMCT income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -11434000.00
CMCT cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -39575000.00
CMCT cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -11566000.00
CMCT income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -39575000.00
CMCT income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -11566000.00
CMCT income_statement (annual, 2025-12-31) — Net Interest Income: -40191000.00
CMCT income_statement (quarterly, 2025-12-31) — Net Interest Income: -9945000.00
CMCT cash_flow (annual, 2025-12-31) — Net Investment Properties Purchase And Sale: 1161000.00
CMCT cash_flow (quarterly, 2025-12-31) — Net Investment Properties Purchase And Sale: 0.00
CMCT cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 20457000.00
CMCT cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -1664000.00
CMCT cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 20457000.00
CMCT cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -1664000.00
CMCT income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -40191000.00
CMCT income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -9945000.00
CMCT cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -2901000.00
CMCT cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 350000.00
CMCT cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 8823000.00
CMCT cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 2405000.00
CMCT cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: -165000.00
CMCT cash_flow (quarterly, 2025-12-31) — Net Preferred Stock Issuance: -157000.00
CMCT balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 264922000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 264922000.00
CMCT balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 7842000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 7842000.00
CMCT income_statement (annual, 2025-12-31) — Normalized EBITDA: 33186000.00
CMCT income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 9260000.00
CMCT income_statement (annual, 2025-12-31) — Normalized Income: -35151540.00
CMCT income_statement (quarterly, 2025-12-31) — Normalized Income: -8418570.00
CMCT cash_flow (annual, 2025-12-31) — Operating Cash Flow: 5788000.00
CMCT cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 3317000.00
CMCT cash_flow (annual, 2025-12-31) — Operating Gains Losses: 3616000.00
CMCT cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 1922000.00
CMCT income_statement (annual, 2025-12-31) — Operating Income: 9747000.00
CMCT income_statement (quarterly, 2025-12-31) — Operating Income: 3815000.00
CMCT income_statement (annual, 2025-12-31) — Operating Revenue: 116669000.00
CMCT income_statement (quarterly, 2025-12-31) — Operating Revenue: 28451000.00
CMCT balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 26996.00
CMCT balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 26996.00
CMCT cash_flow (annual, 2025-12-31) — Other Cash Adjustment Inside Changein Cash: -4423000.00
CMCT balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 21966000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 21966000.00
CMCT income_statement (annual, 2025-12-31) — Other Gand A: 6711000.00
CMCT income_statement (quarterly, 2025-12-31) — Other Gand A: 581000.00
CMCT income_statement (annual, 2025-12-31) — Other Income Expense: -8634000.00
CMCT income_statement (quarterly, 2025-12-31) — Other Income Expense: -5292000.00
CMCT balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 439000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 439000.00
CMCT cash_flow (annual, 2025-12-31) — Other Non Cash Items: 3166000.00
CMCT cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 225000.00
CMCT balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 4732000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 4732000.00
CMCT balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 11406000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 11406000.00
CMCT balance_sheet (annual, 2025-12-31) — Other Receivables: 10850000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Other Receivables: 10850000.00
CMCT income_statement (annual, 2025-12-31) — Other Special Charges: 88000.00
CMCT income_statement (quarterly, 2025-12-31) — Other Special Charges: 0.00
CMCT income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 1439000.00
CMCT income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 1139000.00
CMCT balance_sheet (annual, 2025-12-31) — Payables: 49798000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Payables: 49798000.00
CMCT balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 49798000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 49798000.00
CMCT balance_sheet (annual, 2025-12-31) — Preferred Stock: 310446000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 310446000.00
CMCT cash_flow (annual, 2025-12-31) — Preferred Stock Dividend Paid: -21959000.00
CMCT cash_flow (quarterly, 2025-12-31) — Preferred Stock Dividend Paid: -5282000.00
CMCT income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 21207000.00
CMCT income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 5162000.00
CMCT balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 310446000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 310446000.00
CMCT cash_flow (annual, 2025-12-31) — Preferred Stock Payments: -165000.00
CMCT cash_flow (quarterly, 2025-12-31) — Preferred Stock Payments: -157000.00
CMCT income_statement (annual, 2025-12-31) — Pretax Income: -39078000.00
CMCT income_statement (quarterly, 2025-12-31) — Pretax Income: -11422000.00
CMCT cash_flow (annual, 2025-12-31) — Purchase Of Business: -1208000.00
CMCT cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 1000.00
CMCT balance_sheet (annual, 2025-12-31) — Receivables: 13448000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Receivables: 13448000.00
CMCT income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 73012000.00
CMCT income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 17135000.00
CMCT income_statement (annual, 2025-12-31) — Reconciled Depreciation: 27199000.00
CMCT income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 6920000.00
CMCT income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 67043000.00
CMCT income_statement (quarterly, 2025-12-31) — Rent Expense Supplemental: 16803000.00
CMCT cash_flow (annual, 2025-12-31) — Repayment Of Debt: -35047000.00
CMCT cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -5633000.00
CMCT cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -165000.00
CMCT cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -157000.00
CMCT balance_sheet (annual, 2025-12-31) — Restricted Cash: 22246000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 22246000.00
CMCT income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 1475000.00
CMCT income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 48000.00
CMCT balance_sheet (annual, 2025-12-31) — Retained Earnings: -1064132000.00
CMCT balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -1064132000.00
CMCT cash_flow (annual, 2025-12-31) — Sale Of Business: 30000.00